Publications by authors named "Goro Kasuya"

Claim this Profile
T
The clinical relative biological effectiveness and prostate-specific antigen kinetics of carbon-ion radiotherapy in low-risk prostate cancer.
Yu-Mei Kang, Hitoshi Ishikawa, Taku Inaniwa, Yuma Iwai, Naruhiro Matsufuji, Goro Kasuya

Cancer Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancer.
Hiraku Sato, Goro Kasuya, Hitoshi Ishikawa, Akihiro Nomoto, Takashi Ono

Cancer Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk Factors for Radiation Pneumonitis After Single-Fraction Carbon-Ion Radiotherapy for Lung Cancer or Metastasis.
Takashi Ono, Naoyoshi Yamamoto, Akihiro Nomoto, Mio Nakajima, Yuma Iwai, Goro Kasuya

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-small Cell Lung Cancer.
Takashi Ono, Naoyoshi Yamamoto, Akihiro Nomoto, Mio Nakajima, Yuka Isozaki, Goro Kasuya

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of SPECT-CT fusion images and semi-quantitative evaluation using SUV in I-IMP SPECT in patients with choroidal melanoma.
Kana Yamazaki, Ryuichi Nishii, Takamasa Maeda, Hirokazu Makishima, Goro Kasuya

Ann Nucl Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer.
Yoko Ikoma, Riwa Kishimoto, Yasuhiko Tachibana, Tokuhiko Omatsu, Goro Kasuya

Magn Reson Imaging· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavy charged particles for gastrointestinal cancers.
Yuka Isozaki, Hirotoshi Takiyama, Tapesh Bhattacharyya, Daniel Ebner, Goro Kasuya

J Gastrointest Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry.
Tapesh Bhattacharyya, Masashi Koto, Hiroaki Ikawa, Kazuhiko Hayashi, Yasuhito Hagiwara, Goro Kasuya

Br J Radiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma.
Shigeo Yasuda, Hirotoshi Kato, Hiroshi Imada, Yuka Isozaki, Goro Kasuya

Adv Radiat Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS).
Goro Kasuya, Kazuki Terashima, Kei Shibuya, Shingo Toyama, Daniel K Ebner

Oncotarget· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Osama Mohamad, Takahiro Tabuchi, Yuki Nitta, Akihiro Nomoto, Akira Sato, Goro Kasuya

Lancet Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
Hirokazu Makishima, Shigeo Yasuda, Yuka Isozaki, Goro Kasuya, Naomi Okada

Cancer Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma.
Goro Kasuya, Hiroshi Tsuji, Takuma Nomiya, Hirokazu Makishima, Yasuo Haruyama

Oncotarget· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma.
Goro Kasuya, Hiroshi Tsuji, Takuma Nomiya, Hirokazu Makishima, Yasuo Haruyama

Cancer Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
Goro Kasuya, Hitoshi Ishikawa, Hiroshi Tsuji, Yasuo Haruyama, Gen Kobashi

Cancer Sci· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials.
Goro Kasuya, Hirotoshi Kato, Shigeo Yasuda, Hiroshi Tsuji, Shigeru Yamada

Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Goro Kasuya, Hitoshi Ishikawa, Hiroshi Tsuji, Takuma Nomiya, Hirokazu Makishima

Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Carbon ion radiotherapy].
Goro Kasuya, Hiroshi Tsuji

Nihon Rinsho· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent use of strontium-89 with external beam radiotherapy for multiple bone metastases: early experience.
Joichi Heianna, Takafumi Toita, Wataru Endo, Goro Kasuya, Takuro Ariga

Ann Nucl Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer].
Takafumi Toita, Takuro Ariga, Goro Kasuya, Seiji Hashimoto, Hitoshi Maemoto

Gan To Kagaku Ryoho· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent chemoradiotherapy for non-bulky stage IB/II cervical cancer without pelvic node enlargement.
Akihiko Wakayama, Morihiko Inamine, Wataru Kudaka, Yutaka Nagai, Tomoko Nakamoto, Goro Kasuya

Anticancer Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
Takuro Ariga, Takafumi Toita, Goro Kasuya, Yutaka Nagai, Morihiko Inamine

J Radiat Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.
Goro Kasuya, Takafumi Toita, Kazuhisa Furutani, Takeshi Kodaira, Tatsuya Ohno

Radiat Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Goro Kasuya, Kazuhiko Ogawa, Shiro Iraha, Yutaka Nagai, Makoto Hirakawa

Anticancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical radiotherapy for superficial esophageal cancer: impact of clinical N stage on survival.
Takuro Ariga, Kazuhiko Ogawa, Hideaki Shimoji, Hiroyuki Karimata, Takafumi Toita, Goro Kasuya

Anticancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis